Phase 1 study of CA-4948, a novel inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) in patients (pts) with r/r non-Hodgkin lymphoma Meeting Abstract
| Authors: | Rosenthal, A. C.; Tun, H. W.; Younes, A.; Nowakowski, G. S.; Lunning, M. A.; Patel, K.; Landsburg, D. J.; Martell, R. E.; Leslie, L. A. |
| Abstract Title: | Phase 1 study of CA-4948, a novel inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) in patients (pts) with r/r non-Hodgkin lymphoma |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Language: | English |
| ACCESSION: | WOS:000487345802403 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.e19055 |
| Notes: | Meeting Abstract: e19055 -- Source: Wos |
